E³ - Advanced Courses: Cancer Imaging

E³ 1018 - Multimodality imaging of tumour heterogeneity in cancer treatment: a multidisciplinary approach

March 3, 14:00 - 15:30 CET

E³ 1018-1
5 min
Chairperson's introduction
Clemens C. Cyran, Munich / Germany
1. To define the concept of tumour heterogeneity and its role in future therapeutic strategies in oncology.
2. To discuss the pathological hallmarks of clonal heterogeneity and their underlying pathophysiological relevance.
3. To explore multimodality imaging biomarkers of tumour heterogeneity in vivo and their potential for therapy guidance.
4. To discuss the potential of integrated multi-diagnostic biomarkers for guiding therapy in oncology.
E³ 1018-2
15 min
The oncologist: the rationale of tumour heterogeneity in oncology
Manuela Schmidinger, Vienna / Austria
E³ 1018-3
15 min
The pathologist: pathological assessment and measures of clonal heterogeneity
Federica Pedica, Milan / Italy
E³ 1018-4
15 min
Multimodality imaging of tumour heterogeneity
Clemens C. Cyran, Munich / Germany
E³ 1018-5
40 min
Case-based panel discussion: Integrated biomarkers of tumour heterogeneity for guiding oncological therapy
Clemens C. Cyran, Munich / Germany

Moderators

Moderator

Clemens C. Cyran

München, Germany

Speakers

Presenter

Clemens C. Cyran

München, Germany

Presenter

Manuela Schmidinger

Vienna, Austria

Presenter

Federica Pedica

Milan, Italy